Literature DB >> 20610914

Clinical experience with the active middle ear implant Vibrant Soundbridge in sensorineural hearing loss.

S M Pok, M Schlögel, K Böheim.   

Abstract

BACKGROUND/AIMS: To evaluate gain at threshold level and speech recognition performance of 54 subjects with mild-to-severe symmetrical sensorineural hearing loss (SNHL) that received the active middle ear implant system Vibrant Soundbridge (VSB).
METHODS: Pre- and postoperative assessments of hearing thresholds and monosyllabic word discrimination were performed in a homogeneous group of 54 adults who received a VSB system (VORP 502/AP 404) in an active middle ear implant (AMEI) program in a tertiary referral hospital. All subjects included in this study had mild-to-severe, predominately sloping SNHL. Gain at threshold level and speech recognition results were assessed for unaided and aided conditions using the patient's walk-in hearing aid (HA) and the VSB in a retrospective study design.
RESULTS: A comparison of pre- and postoperative unaided air conduction thresholds revealed a mean decrease in pure tone averages of 3.9 dB (0.25-8 kHz). Gain at threshold level (unaided thresholds minus AMEI-aided thresholds) was, on average, 20.9 dB at 0.5 kHz, 20.5 dB at 1 kHz, 23.8 dB at 2 kHz, 30.2 dB at 3 kHz, 36.1 dB at 4 kHz, 37.6 dB at 6 kHz and 37.9 dB at 8 kHz. Monosyllabic word discrimination at 65 dB SPL improved from a mean of 30% in the unaided condition to 44% for the HA-aided condition (p<0.05), with a further increase to 57% for the VSB-aided condition (p<0.05, compared to the HA).
CONCLUSION: The AMEI system VSB can be considered as an effective rehabilitation alternative in subjects with mild-to-severe SNHL and unsatisfying benefit from conventional hearing aids. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20610914     DOI: 10.1159/000318522

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  6 in total

Review 1.  Systematic review to evaluate the safety, efficacy and economical outcomes of the Vibrant Soundbridge for the treatment of sensorineural hearing loss.

Authors:  Karl-Ludwig Bruchhage; Anke Leichtle; Rainer Schönweiler; Ingo Todt; Wolf-Dieter Baumgartner; Henning Frenzel; Barbara Wollenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-31       Impact factor: 2.503

Review 2.  [Differential indication of active middle ear implants].

Authors:  K Braun; H-P Zenner; N Friese; A Tropitzsch
Journal:  HNO       Date:  2015-06       Impact factor: 1.284

3.  Long-term functional outcome and satisfaction of patients with an active middle ear implant for sensorineural hearing loss compared to a matched population with conventional hearing aids.

Authors:  Friedrich Ihler; Julian Bewarder; Jenny Blum; Christoph Matthias; Martin Canis
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-19       Impact factor: 2.503

Review 4.  Beyond Tympanomastoidectomy: A Review of Less Common Postoperative Temporal Bone CT Findings.

Authors:  A Panda; M L Carlson; F E Diehn; J I Lane
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-12       Impact factor: 3.825

Review 5.  Implantable hearing devices.

Authors:  Matthias Tisch
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2017-12-18

6.  Progressive Sensorineural Hearing Loss in Vibrant Soundbridge Users Requiring Cochlear Implantation.

Authors:  Faris F Brkic; Wolf-Dieter Baumgartner; Dominik Riss; Thomas Thurner; David T Liu; Wolfgang Gstöttner; Erich Vyskocil
Journal:  J Pers Med       Date:  2022-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.